Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-01

FDA Approved: DYMISTA — Original Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved DYMISTA (azelastine hydrochloride and fluticasone propionate) under an Original Application by Viatris Specialty LLC, introducing a fixed-dose nasa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DYMISTA (azelastine hydrochloride and fluticasone propionate)

Snippet

ORIG AP for DYMISTA (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE)